Heme/NADH Mimics Co‐Decorated Allosteric Capsules for Regulating Oxygen Activation and Upregulating Intracellular Methionine Depletion
Source abstract
Abstract
Abstract Stimuli‐responsive behaviors in living bodies provide the fundamental principles for developing switchable architectures that apply to the direct function regulation. Herein, by incorporating both the µ ‐oxo bridged Fe III ‐porphyrins and NADH (nicotinamide adenine dinucleotide) mimics into an allosteric coordination capsule, the regulation of O 2 activation and the upregulation of intracellular methionine depletion have been achieved, resulting in effective pH‐activated tumor immunotherapy. Upon light irradiation, the transition from the tensed bridged Fe III ‐porphyrins to the relaxed unbridged Fe IV = O/Fe II porphyrin pair induces unique conformational switching. The relaxed state of the capsule facilitates the binding of substrates for the oxygen atom transfer reaction. The in situ formed Fe II ‐porphyrin pair, following the substrate oxygenation, activates O 2 with the intervention of NADH mimics to restore the tensed state of the capsule, thereby releasing the product for the next cycle. Regulated by the acid/base content in the system, this allostery‐triggered metabolic behavior enhances the efficacy of intracellular methionine depletion therapy through the accumulation of local methionine sulfoxide, thereby improving safety. The allosteric switching strategy offers an improved approach for precise tumor treatment via dual light‐and‐guest stimuli‐responsive regulation.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Supramolecular Chemistry and Complexes · Molecular Sensors and Ion Detection
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Fine Chemicals Dalian University of Technology Dalian 116024 P. R. China
State Key Laboratory of Coordination Chemistry Nanjing University Nanjing 210023 P. R. China
Funding
National Natural Science Foundation of China · China Postdoctoral Science Foundation
References (61)
Show source-provided references
1. 10.1016/j.tibs.2008.05.00910.1016/j.tibs.2008.05.009 ↗
2. 10.1038/nchembio.9810.1038/nchembio.98 ↗
3. 10.1038/s41565-019-0401-610.1038/s41565-019-0401-6 ↗
4. 10.1021/jacs.5b0105410.1021/jacs.5b01054 ↗
5. 10.1002/anie.20200105910.1002/anie.202001059 ↗
6. 10.1002/anie.20230533810.1002/anie.202305338 ↗
7. 10.1039/D0CS00801J10.1039/D0CS00801J ↗
8. 10.1021/jacs.9b1109910.1021/jacs.9b11099 ↗
9. 10.1021/jacs.0c1218810.1021/jacs.0c12188 ↗
10. 10.1002/anie.20100038010.1002/anie.201000380 ↗
11. 10.1021/acs.chemrev.2c0075910.1021/acs.chemrev.2c00759 ↗
12. 10.1021/jacs.1c0639010.1021/jacs.1c06390 ↗
13. 10.1038/s41591-019-0423-510.1038/s41591-019-0423-5 ↗
14. 10.1016/j.tips.2024.03.00210.1016/j.tips.2024.03.002 ↗
15. 10.1038/s41467-023-36630-w10.1038/s41467-023-36630-w ↗
16. 10.1016/j.tem.2024.01.00910.1016/j.tem.2024.01.009 ↗
17. 10.1038/s41467-023-40518-010.1038/s41467-023-40518-0 ↗
18. 10.1021/ja500380e10.1021/ja500380e ↗
19. 10.1021/acs.chemrev.1c0102110.1021/acs.chemrev.1c01021 ↗
20. 10.1039/D0CS01297A10.1039/D0CS01297A ↗
21. 10.1021/acs.chemrev.7b0037310.1021/acs.chemrev.7b00373 ↗
22. 10.1039/C9CS00917E10.1039/C9CS00917E ↗
23. 10.1016/j.redox.2023.10283410.1016/j.redox.2023.102834 ↗
24. 10.1186/s13046-023-02832-910.1186/s13046-023-02832-9 ↗
25. 10.1016/j.ccr.2021.21427610.1016/j.ccr.2021.214276 ↗
26. 10.1021/jacsau.2c0032210.1021/jacsau.2c00322 ↗
27. 10.1021/cr300282410.1021/cr3002824 ↗
28. 10.1002/anie.20231437810.1002/anie.202314378 ↗
29. 10.1039/D0CS00038H10.1039/D0CS00038H ↗
30. 10.1142/S108842461930025810.1142/S1088424619300258 ↗
31. 10.1002/anie.20030063710.1002/anie.200300637 ↗
32. 10.1002/chem.20180350110.1002/chem.201803501 ↗
33. 10.1021/ic801423g10.1021/ic801423g ↗
34. 10.1021/ja108821p10.1021/ja108821p ↗
35. 10.1039/D2CY01081J10.1039/D2CY01081J ↗
36. 10.1021/ja058731s10.1021/ja058731s ↗
37. 10.1021/ja026017u10.1021/ja026017u ↗
38. 10.1021/acs.analchem.0c0214910.1021/acs.analchem.0c02149 ↗
39. 10.1016/j.cej.2022.13694110.1016/j.cej.2022.136941 ↗
40. 10.1021/ja045877310.1021/ja0458773 ↗
41. 10.1021/jacs.6b0525110.1021/jacs.6b05251 ↗
42. 10.1021/jacs.8b0656810.1021/jacs.8b06568 ↗
43. 10.1002/anie.20221457710.1002/anie.202214577 ↗
44. 10.1021/jacs.4c0705810.1021/jacs.4c07058 ↗
45. 10.1002/anie.20231960510.1002/anie.202319605 ↗
46. 10.1002/anie.20241489410.1002/anie.202414894 ↗
47. 10.1038/s41568-019-0187-810.1038/s41568-019-0187-8 ↗
48. 10.1016/j.arr.2021.10150010.1016/j.arr.2021.101500 ↗
49. 10.3390/antiox1301002110.3390/antiox13010021 ↗
50. 10.1016/j.jconrel.2020.02.00710.1016/j.jconrel.2020.02.007 ↗
51. 10.1016/j.biomaterials.2014.02.01110.1016/j.biomaterials.2014.02.011 ↗
52. 10.1002/adma.20230820510.1002/adma.202308205 ↗
53. 10.1007/s11010-016-2843-610.1007/s11010-016-2843-6 ↗
54. 10.1002/adma.20230383510.1002/adma.202303835 ↗
55. 10.1038/nbt.164110.1038/nbt.1641 ↗
56. 10.7150/thno.7846710.7150/thno.78467 ↗
57. 10.1186/s12951-016-0162-410.1186/s12951-016-0162-4 ↗
58. 10.1002/anie.20190538910.1002/anie.201905389 ↗
59. 10.1146/annurev-physiol-021119-03462710.1146/annurev-physiol-021119-034627 ↗
60. 10.1136/jitc-2019-00033910.1136/jitc-2019-000339 ↗
61. 10.1039/B617136B10.1039/B617136B ↗